Shares of biopharmaceutical company MediWound Ltd. (MDWD) were down more than 12 percent in pre-market on Monday to $18.60, after announcing private placement of 1.45 million shares at $17.20 per share.
The company has entered into share purchase agreement with several new and existing investors, including Molnlycke Health Care, a MedTech company specializing in solutions for wound care and surgical procedures.
MediWound intends to use the gross proceeds from the private investment in public equity or PIPE offering of $25 million to advance EscharEx pre-commercial activities, accelerate the development of large-scale manufacturing capabilities specifically for EscharEx, and for general corporate purposes.
MediWound shares had closed at $21.16, up 5.27 percent on Friday. The stock has traded in the range of $7.10 - $24.00 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.